|
Jeff Hutchins, Ph.D. has served as Vice President of PreClinical Development since 2007. He served as Director of Monoclonal Antibody Development from 2001 to 2007. From 1991 through 2000 he held several Senior Scientist positions in Discovery Research at Glaxo Wellcome with a visiting professor appointment in the Department of Biochemistry at Rush Medical College. Dr. Hutchins received a B.S. in Biology from Oral Roberts University, a Ph.D. in Biomedical Sciences from the University of Texas, Health Science Center at Houston Graduate School of Biomedical Sciences and postdoctoral training from University of Southern California Department of Microbiology. Dr. Hutchins publications and patents span the fields of infectious disease, immunology, oncology and osteoarthritis. | 